Yanfen Zou

Yanfen Zou


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2014 in Molecules
Verified
Journal Article
Open access
PDF file
YZYanfen Zou
Yanfen Zou
QZQing Zuo
Qing Zuo
SHShiyun Huang
Shiyun Huang
XYXiang Yu
Xiang Yu
ZJZiyan Jiang
Ziyan Jiang
LSLizhou Sun
Lizhou Sun
Resveratrol has been shown to be a therapeutic agent for cardiovascular disorders by maintaining a lower redox level in vivo through its anti-oxidant properties. Resveratrol can prevent cells from p53- and reactive oxygen species-dependent apoptosis induced by interleukin-1b. We identified an inhibitory effect of resveratrol against oxidative stress and apoptosis using the TUNEL assay in NG-Nitro-l-arginine methyl ester-induced preeclampsia in rats. To investigate a possible association between resveratrol and the apoptosis caused by oxidative stress in vitro, assays for superoxide dismutase and malondialdehyde as well as flow cytometric analyses were conducted in HTR-8/SVneo cells after hypoxic treatment with or without resveratrol for 24 h. These data suggest that resveratrol significantly opposes the effects of oxidative stress in vivo and in vitro.

21 February 2017 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
XYXiang Yu
Xiang Yu
YLYang Lin
Yang Lin
WSWu Sui
Wu Sui
YZYanfen Zou
Yanfen Zou
ZLZhongchuan Lv
Zhongchuan Lv
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies with the worst prognosis. Recent studies have demonstrated that long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis and cancer progression. However, the expression pattern and roles of lncRNAs in the development of PDAC remain unknown. Herein, we globally analyzed the lncRNA expression profile in human PDAC and non‐tumor tissues using four independent public microarray datasets from Gene Expression Omnibus (GEO). The analysis of GEO datasets by repurposing microarray probes confirmed that hundreds of lncRNAs are differentially expressed in PDAC tissues compared with normal tissues. We selected four lncRNAs including LINC00152, CASC9, LINC00226 and F11‐AS1 for validation in PDAC cell lines and normal cells. Loss of function assays were performed to investigate the roles of LINC00152 and CASC9 in PDAC cell proliferation and invasion. Taken together, our findings demonstrate lncRNA expression alterations in PDAC and may provide new potential molecular markers for PDAC patient diagnosis and treatment.

23 September 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
XXXue Xu
Xue Xu
YXYongcan Xu
Yongcan Xu
CSChuanqin Shi
Chuanqin Shi
BWBaoyu Wang
Baoyu Wang
XYXiang Yu
Xiang Yu
THTao Hu
Tao Hu
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Xue Xu1, *, Yongcan Xu2, *, Chuanqin Shi1, Baoyu Wang1, Xiang Yu3, Yanfen Zou4 and Tao Hu1 1Department of Immunology, Binzhou Medical College, 264003, China 2Department of general surgery, Huzhou Central Hospital, Huzhou 313000, China 3Department of General Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China 4Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China *These authors have contributed equally to this work Correspondence to: Tao Hu, email: hutao0408@sina.com Yanfen Zou, email: zouyanfen2011@163.com Xiang Yu, email: yuxiang861120@163.com Keywords: renal cell carcinoma, lncRNAs profiling, metastasis, prognosis, marker Received: July 04, 2017 Accepted: August 04, 2017 Published: September 23, 2017 ABSTRACT Recently, a growing number of studies have indicated that long noncoding RNAs (lncRNAs) are emerging as new critical regulators of tumorigenesis and prognostic markers in multiple cancers. However, the expression pattern of lncRNAs and their contributions in renal cell carcinoma (RCC) remains poorly understood. In this study, we performed a genome-wide comprehensively analysis of lncRNAs profiling and clinical relevance to provide valuable lncRNA candidates for the further study in RCC. RCC and non-tumor tissues RNA sequencing data, and microarray data were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO), then, these data were annotated and analyzed to find dysregulated lncRNAs in RCC. We identified that hundreds of lncRNAs were differentially expressed in RCC tissues compared with normal tissues, and genomic variation analyses revealed that copy number amplification or deletion happened in some of these lncRNAs genome loci. Moreover, lots of lncRNAs expression levels are significantly associated RCC patients overall survival time, such as PVT1 and DUXAP8. Finally, we identified some novel metastasis associated lncRNAs in RCC (such as DUXAP8) by analyzing lncRNAs profiling in the RCC tissues from patients with metastasis compared with the primary RCC tissues without metastasis; knockdown of DUXAP8 could impair RCC cells invasive ability in vitro. Overall, our findings illuminate a lot of lncRNAs are aberrantly expressed in RCC that may offer useful resource for identification novel prognostic markers in this disease.

16 August 2021 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
WYWeiwei Yang
Weiwei Yang
XWXiaoyan Wang
Xiaoyan Wang
SSShujie Song
Shujie Song
YCYongli Chu
Yongli Chu
DSDengjun Sun
Dengjun Sun
YZYanfen Zou
Yanfen Zou
Cervical cancer is a common female malignancy worldwide, and the molecular mechanism of cervical tumorigenesis remains poorly understood. A large piece of evidence have demonstrated the important roles of long noncoding RNAs (lncRNAs) in tumorigenesis, cancer progression and drug resistance. In this study, we comprehensively analyzed the lncRNAs expression pattern in cervical cancer using RNA sequencing and microarray data from the cancer genome atlas, gene expression omnibus and Genotype Tissue Expression. Moreover, we assessed the correlation between lncRNA expression levels and cervical cancer patient’s survival. We uncovered hundreds of lncRNAs that are upregulated or downregulated in cervical cancer tissues. Among these aberrantly lncRNAs, some are significantly associated with cervical patients’ poorer prognosis, such as ALOX12-AS1 and LINC00173. ALOX12-AS1 expression is downregulated in cervical cancer, and over-expression of ALOX12-AS1 could inhibit cervical cancer cells proliferation in vitro. Further, mechanistically investigation revealed that ALOX12-AS1 could interact with AGO2 and sponge miR-3171, thereby antagonizing its’ repression of tumor suppressor phosphatase and tensin homolog expression in cervical cancer cell. Taken together, this study provides lncRNA candidates in cervical cancer and highlights the critical role of ALOX12-AS1 in cervical cancer.

13 October 2021 in Aging
Verified
Journal Article
Open access
RDRuisong Ding
Ruisong Ding
XHXingyou Hu
Xingyou Hu
WHWen Hu
Wen Hu
ZDZhenzhen Du
Zhenzhen Du
PHPanpan Huang
Panpan Huang
THTao Hu
Tao Hu
Cosmc mutations may cause abnormal O-glycosylation and result in Tn antigen expression. In the current study, it was discovered that proliferation and migration of Tn(+) cells (Jurkat T and LS174T-Tn(+) cells) with mutant Cosmc decreased after transfected Cosmc, and their sensitivity to apoptosis induced by Apo2L/TRAIL increased. Core 1-, 2-, and 3-derived O-glycans were absent in Tn(+) cells. After Cosmc transfection, normal extended core 1-derived O-glycans appeared and were accompanied by increased T-synthase activity. Core 2-derived O-glycans appeared in transfected LS174T-Tn(+) cells, and their structural types and levels were lower than those in LS174T-Tn(-) cells. Core 3-derived O-glycans were present only in LS174T-Tn(-) cells. The activity of C3GnT in LS174T-Tn(+) cells was lower than that in LS174T-Tn(-) cells, and it was absent in Jurkat T cells. Cosmc transfection did not alter C3GnT activity or core 3-derived O-glycans in Jurkat T and LS174T-Tn(+) cells. The results demonstrated that the composition and structure of O-glycans were different among various Tn(+) cells, which not only affected cell malignant behavior but also modulated sensitivity to apoptotic stimuli. Thus, Cosmc transfection may effectively decrease the malignant behavior of Tn(+) tumor cells and enhance their sensitivity to apoptosis when induced by Apo2L/TRAIL through modification of O-glycans.